The WHO explained Thursday that it's got fielded numerous reports of pretend semaglutide — the Lively ingredient in Novo Nordisk's Wegovy and Ozempic — in all geographic regions of the world considering the fact that 2022. to decrease the chance of major cardiovascular functions which include coronary heart assault, stroke, or Loss of life in